Morgan Stanley’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 8085 |
|
|
2025
Q1 | $2 | Sell |
1
-1
| -50% | -$2 | ﹤0.01% | 8069 |
|
|
2024
Q4 | $4 | Hold |
2
| – | – | ﹤0.01% | 7936 |
|
|
2024
Q3 | $5 | Sell |
2
-1
| -33% | -$3 | ﹤0.01% | 7887 |
|
|
2024
Q2 | $7 | Hold |
3
| – | – | ﹤0.01% | 7798 |
|
|
2024
Q1 | $9 | Sell |
3
-5
| -63% | -$15 | ﹤0.01% | 7776 |
|
|
2023
Q4 | $18 | Buy |
8
+5
| +167% | +$11 | ﹤0.01% | 7761 |
|
|
2023
Q3 | $8 | Sell |
3
-18
| -86% | -$48 | ﹤0.01% | 7569 |
|
|
2023
Q2 | $60 | Sell |
21
-10
| -32% | -$29 | ﹤0.01% | 7529 |
|
|
2023
Q1 | $90 | Sell |
31
-24
| -44% | -$70 | ﹤0.01% | 7579 |
|
|
2022
Q4 | $161 | Buy |
55
+24
| +77% | +$70 | ﹤0.01% | 7662 |
|
|
2022
Q3 | $0 | Sell |
31
-2,495
| -99% | – | ﹤0.01% | 7830 |
|
|
2022
Q2 | $6K | Sell |
2,526
-59,343
| -96% | -$141K | ﹤0.01% | 7366 |
|
|
2022
Q1 | $142K | Sell |
61,869
-6,264
| -9% | -$14.4K | ﹤0.01% | 6110 |
|
|
2021
Q4 | $170K | Buy |
68,133
+66,784
| +4,951% | +$167K | ﹤0.01% | 6145 |
|
|
2021
Q3 | $4K | Buy |
+1,349
| New | +$4K | ﹤0.01% | 7550 |
|